Prøve GULL - Gratis
IIM-Rohtak sends director on leave till probe is over
Financial Express Chandigarh
|April 09, 2025
FOLLOWING THE CENTRAL government's decision to launch an inquiry against IIM-Rohtak director Dheeraj Sharma, the institute's Board of Governors (BoG), in a meeting held last month, unanimously decided to send him on leave and also instructed him to move out of campus until the inquiry is over, it has been learnt.
As first reported on February 24, the Centre had sought President Droupadi Murmu's approval to launch an inquiry into the misappropriation of public funds at IIM-Rohtak during Sharma's tenure, including the use of manipulated figures to pay huge amounts of variable salary to him.
The inquiry order was issued on March 5 and IIM-Mumbai director professor Manoj Tiwari has been asked to submit his report within three months.
With Sharma under scrutiny for allegedly misrepresenting his educational qualifications to secure his initial term as IIM-Rohtak director in 2017, the institute's failure to send Sharma's degree certificate to the ministry of education despite repeated requests will also be probed.
According to the minutes of the BoG meeting held on March 20, the Board took up the matter of the visitorial inquiry against Sharma after receiving two letters from the ministry of education on March 13 and March 19. The Board then decided to send him on leave till the completion of the inquiry and to also ask him to stay away from all campuses/rented areas of IIM-Rohtak till further orders. The minutes also state that Sharma would be given reasonable time to move out.
Denne historien er fra April 09, 2025-utgaven av Financial Express Chandigarh.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Financial Express Chandigarh
Financial Express Chandigarh
'Global norms ensure domestic crypto investor safety'
The long-term goal of Binance Holdings, the world’s largest crypto exchange in terms of volumes, is to become a collaborative partner for India’s blockchain and digital asset ecosystem, SB Seker, head of the Asia-Pacific region, an interview.
2 mins
December 13, 2025
Financial Express Chandigarh
Govt speeds up visa for Chinese professionals
• Processing time less than 1 month now; China sees ‘positive action’
1 min
December 13, 2025
Financial Express Chandigarh
Rupee hits fresh closing low, drift may continue
It touched 90.56 against the dollar intra day
1 mins
December 13, 2025
Financial Express Chandigarh
Silver hits ₹2 lakh in futures trade
SILVER PRICES RALLIED on Friday to breach the record ₹2 lakh per kg mark in futures trade for the first time, riding on strong investor demand and positive global trends.
1 min
December 13, 2025
Financial Express Chandigarh
INITIATIVE TO COVER CRITICAL MINERALS, CHIPS India left out of US-led supply chain coalition
A NEW US-LED strategic initiative, Pax Silica, which aims to build a secure supply chain ranging from critical minerals and energy inputs to advanced manufacturing and semiconductors, does not include India.
2 mins
December 13, 2025
Financial Express Chandigarh
Vinesh returns to the mat, eyes medal at 2028 Games
STAR WRESTLER VINESH PHOGAT on Friday announced that she would be coming out of retirement to take another shot at an elusive Olympic medal at the 2028 Los Angeles Games as the “the fire never left” her and was merely buried under “exhaustion and noise”.
1 mins
December 13, 2025
Financial Express Chandigarh
Airline moves Delhi HC for ₹900-crore IGST refund
Airline moves Delhi HC for ₹900-crore IGST refund
1 min
December 13, 2025
Financial Express Chandigarh
Ozempic adds to growing...
NOVO NORDISKCLAIMS it also reduces cardiovascular and renal risks.
1 min
December 13, 2025
Financial Express Chandigarh
SBI reduces lending rates after RBI rate cut
STATE BANK OF India (SBI) on Friday revised its lending rates following the Reserve Bank of India’s latest 25-bps reduction in the repo rate.
1 min
December 13, 2025
Financial Express Chandigarh
Ozempic adds to India's growing appetite for anti-obesity drugs
Novo Nordisk launches medicine at starting price of ₹2,200 a week
1 min
December 13, 2025
Listen
Translate
Change font size
